Literature DB >> 26920632

Ischemic preconditioning and remote ischemic preconditioning provide combined protective effect against ischemia/reperfusion injury.

Ding-Yang Li1, Xiao-Ju Shi1, Wei Li2, Xiao-Dong Sun1, Guang-Yi Wang3.   

Abstract

AIMS: Our objective was to compare the protective efficacy of ischemic preconditioning (IPC) and remote ischemic preconditioning (RIPC) against liver ischemia/reperfusion injury (IRI) and to evaluate their combined protective effect in mouse liver transplantation (MLT).
MATERIALS AND METHODS: Mice were randomly allocated to sham, IPC, RIPC, or IPC+RIPC groups. The animals were sacrificed at 2h, 24h, and 3 days after reperfusion. Blood samples were collected to evaluate alanine aminotransferase, TNF-α, and innate immune response. Liver tissue samples were obtained for histological evaluation, terminal deoxynucleotidyltransferased UTP nick end labeling, malondialdehyde (MDA) assay. KEY
FINDINGS: Mice given preconditioning measures had significantly lower increase in transaminase, TNF-α expression, MDA formation, liver injury scores, and apoptosis index at 2h, 24h and 3 days after liver transplantation. The percentages of CD11b(+), CD11b(+)CD16/32(+) and CD11b(+) CD16/32(high) in white blood cells at 3 days after MLT were significantly lower than in the sham group. The results of factorial analysis demonstrated no synergistic effect for IPC and RIPC, except for MDA formation 2h after reperfusion (p=0.038). SIGNIFICANCE: Based on the synergistic and addictive effect on liver IRI induced by MLT between IPC and RIPC, the study suggested ways in which combined preconditionings could be elicited in patients undergoing planned procedures complicated by IRI to support better outcomes.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Ischemia/reperfusion injury; Ischemic preconditioning; Liver transplantation; Remote ischemic preconditioning

Mesh:

Substances:

Year:  2016        PMID: 26920632     DOI: 10.1016/j.lfs.2016.02.077

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  7 in total

Review 1.  An Evaluation of Ischaemic Preconditioning as a Method of Reducing Ischaemia Reperfusion Injury in Liver Surgery and Transplantation.

Authors:  Francis P Robertson; Barry J Fuller; Brian R Davidson
Journal:  J Clin Med       Date:  2017-07-14       Impact factor: 4.241

2.  Impact of combined ischemic preconditioning and remote ischemic perconditioning on ischemia-reperfusion injury after liver transplantation.

Authors:  Ding-Yang Li; Wen-Tao Liu; Guang-Yi Wang; Xiao-Ju Shi
Journal:  Sci Rep       Date:  2018-12-19       Impact factor: 4.379

3.  Remote Ischemic Preconditioning and Diazoxide Protect from Hepatic Ischemic Reperfusion Injury by Inhibiting HMGB1-Induced TLR4/MyD88/NF-κB Signaling.

Authors:  Won Uk Koh; Jiye Kim; Jooyoung Lee; Gi-Won Song; Gyu Sam Hwang; Eunyoung Tak; Jun-Gol Song
Journal:  Int J Mol Sci       Date:  2019-11-24       Impact factor: 5.923

Review 4.  Direct, remote and combined ischemic conditioning in liver surgery.

Authors:  Rafał Stankiewicz; Michał Grąt
Journal:  World J Hepatol       Date:  2021-05-27

5.  FAM3A mediates PPARγ's protection in liver ischemia-reperfusion injury by activating Akt survival pathway and repressing inflammation and oxidative stress.

Authors:  Zhenzhen Chen; Junpei Wang; Weili Yang; Ji Chen; Yuhong Meng; Bin Geng; Qinghua Cui; Jichun Yang
Journal:  Oncotarget       Date:  2017-07-25

6.  Protective Effect of Luteolin Against Renal Ischemia/Reperfusion Injury via Modulation of Pro-Inflammatory Cytokines, Oxidative Stress and Apoptosis for Possible Benefit in Kidney Transplant.

Authors:  Yan Liu; Baoxin Shi; Yi Li; Hui Zhang
Journal:  Med Sci Monit       Date:  2017-12-02

7.  MicroRNA-148b enhances the radiosensitivity of B-cell lymphoma cells by targeting Bcl-w to promote apoptosis.

Authors:  Si-Hong Liu; Pei-Pei Wang; Cun-Te Chen; Dan Li; Qiong-Yao Liu; Lin Lv; Xia Liu; Li-Na Wang; Bao-Xiu Li; Cheng-Yin Weng; Xi-Sheng Fang; Xiao-Fei Cao; Hai-Bo Mao; Xiao-Jun Chen; Shao-Li Luo; Shu-Xiang Zheng; Guo-Long Liu; Yong Wu
Journal:  Int J Biol Sci       Date:  2020-01-23       Impact factor: 6.580

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.